Health Care & Life Sciences » Pharmaceuticals | SymBio Pharmaceuticals Ltd.

SymBio Pharmaceuticals Ltd. | Cash Flow

Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
1,601,424.00
1,112,077.00
2,628,295.00
2,309,433.00
3,974,062.00
Depreciation, Depletion & Amortization
8,163.00
12,663.00
24,244.00
25,649.00
29,569.00
Other Funds
101.00
91.00
90.00
7,539.00
32,560.00
Funds from Operations
1,532,264.00
1,188,373.00
2,461,151.00
1,947,406.00
3,762,891.00
Changes in Working Capital
145,084.00
77,801.00
189,465.00
12,683.00
53,906.00
Net Operating Cash Flow
1,677,348.00
1,266,174.00
2,271,686.00
1,960,089.00
3,816,797.00
Capital Expenditures
-
108,596.00
23,781.00
27,912.00
57,021.00
Purchase/Sale of Investments
1,332,624.00
423,009.00
1,512,922.00
15,923.00
20,485.00
Net Investing Cash Flow
1,332,254.00
314,413.00
1,489,141.00
43,836.00
77,507.00
Issuance/Reduction of Debt, Net
682.00
499,318.00
692.00
2,999,358.00
-
Net Financing Cash Flow
4,056,658.00
543,700.00
2,632.00
3,658,177.00
1,164,230.00
Net Change in Cash
1,054,115.00
202,061.00
830,636.00
1,457,887.00
2,772,265.00
Free Cash Flow
1,677,348.00
1,310,724.00
2,294,232.00
1,983,945.00
3,827,454.00
Other Sources
370.00
-
-
-
-
Change in Capital Stock
4,057,441.00
44,473.00
1,850.00
666,360.00
1,131,670.00
Exchange Rate Effect
7,059.00
206,000.00
45,459.00
196,365.00
42,195.00
Miscellaneous Funds
-
-
-
-
4.00

About SymBio Pharmaceuticals

View Profile
Address
Toranomon 30 Mori Building
Tokyo Tokyo 105
Japan
Employees -
Website http://www.symbiopharma.com
Updated 09/14/2018
SymBio Pharmaceuticals Ltd. engages in the pharmaceutical business. It researches, develops, manufactures, and sells new drugs focusing on the areas of oncology, hematology, and autoimmune diseases. The company was founded on March 25, 2005 by Fuminori Yoshida and is headquartered in Tokyo, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.